Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 47, Issue 2, 2008, Pages 180-188

  Palumbo, Donna R ^a   Sallee, Floyd R ^b,f   Pelham Jr , William E ^c   Bukstein, Oscar G ^d   Daviss, W Burleson ^d,e   McDermott, Michael P ^a   Burrows MacLean, Lisa ^a   Como, Peter ^a   Hoffman, Martin T ^c   Lock, Thomas M ^g   Nelson, Daniel ^b   McConville, Brian ^b   Janciuras, Joanne ^a   Bean, Stephen A ^a   Raab, Dana ^h   Arnold, Francis ^c   Kipp, Heidi ^d   Pearson, Nancy ^a   Vierhile, Amy ^a   Russell, Brad ^b   Tresco, Katy ⁱ   Cannon, Michael ^b   Maher, Susan ^a   Marcus, David ^h   Riggs, Garrett ^a   Robb, Adelaide ^j   Harris, Peter ^a   Richard, Irene ^a   Sulkes, Stephen ^a   Christopher Cox, ^k   Kurlan, Roger ^a   Conners, Keith ^l   Hunt, Robert ^h   Kieburtz, Karl ^a   De Blieck, Elisabeth ^a   Lindsay, Patricia ^a   Preston, Larry ^a   Rothenburgh, Karen ^a   Julian Baros, Elaine ^a   Orme, Connie ^a   Kamp, Dee ^a   Thompson, Lisa ^a   more..

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF OKLAHOMA   (United States)

^h Lehigh University ^*

ⁱ LEHIGH UNIVERSITY   (United States)

^j Washington Children's Hospital

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l DUKE UNIVERSITY   (United States)

more..

Author keywords

Attentiondeficit hyperactivity disorder; Clinical trials; Clonidine; Methylphenidate

Indexed keywords

CLONIDINE; METHYLPHENIDATE; PLACEBO;

ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONNERS TEACHERS ABBREVIATED SYMPTOM QUESTIONNAIRE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FACTORIAL DESIGN; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QT PROLONGATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEDATION; SIDE EFFECT; TACHYCARDIA; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 38549149224     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e31815d9af7     Document Type: Article

References (25)

1. Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;38:1551-1559.
2. Hazell PI, Stewart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry. 2003;42:886-894.
3. Tourette's Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002;58:527-536.
4. Cantwell DP, Swanson J, Connor DF. Case study: adverse response to clonidine. J Am Acad Child Adolesc Psychiatry. 1997;36:539-544.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV. Washington, DC: American Psychiatric Association; 1994.
6. Fisher PW, Shaffer D, Piacentini JC. Sensitivity of the Diagnostic Interview Schedule for Children, 2nd edition (DISC-2.1) for specific diagnoses of children and adolescents. J Am Acad Child Adolesc Psychiatry. 1993;32:666-673.
7. Pelham WE, Gnagy EM, Greenslade KE, et al. Teacher ratings of DSM-III-R symptoms of the disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry. 1992;31:210-218.
8. Pelham WE, Milich R, Murphy DA, et al. Normative data on the Iowa Conners Teacher Rating Scale. J Clin Child Psychol. 1989;18:259-262.
9. Shaffer D, Gould MS, Brasic J. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry. 1983;40:1228-1231.
10. Atkins MS, Pelham WE. A comparison of objective classroom measures and teacher ratings of attention deficit disorder. J Abnorm Child Psychol. 1985;3:155-167.
11. Tanner JM. Growth in Adolescence, 2nd ed. Oxford: Blackwell Scientific; 1962.
12. Wechsler D. Wechsler Intelligence Scale for Children, Third Edition. San Antonio, TX: Psychological Corporation; 1991.
13. Goyette CH, Conners CK, Ulrich RF. Normative data on Revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol. 1978;6:221-236.
14. Conners CK. Conners' Continuous Performance Test. Toronto: Multi-Health Systems; 1995.
15. Wechsler D. Wechsler Individual Achievement Test-Second Edition (WIAT-II). San Antonio, TX: Psychological Corporation; 2004.
16. Pelham WE. Pharmacotherapy for children with attention-deficit hyperactivity disorder. School Psychol Rev. 1993;22:199-227.
17. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1073-1086.
18. Conners CK, Barkley RA. Rating scales and checklists for psychopharmacologic trials. Psychopharmacol Bull. 1985;21:809-854.
19. Gadow KG, Nolan EE, Sverd J. Methylphenidate in hyperactive boys with comorbid tic disorder: I. Short-term behavioral effects in school settings. J Am Acad Child Adolesc Psychiatry. 1992;31:462-471.
20. Leckman JF, Hardin MT, Riddle MA, et al. Clonidine treatment of Gilles de la Tourette syndrome. Arch Gen Psychiatry. 1991;48:324-328.
21. Singer HS, Brown J, Quaskey S, et al. The treatment of attention-deficit hyperactivity disorder in Tourette syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics. 1995;95:74-81.
22. Daviss WB, Patel NC. Robb AS, et al. Clonidine for attention-deficit/ hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry. 2008;47:189-198.
23. Chappell PB, Riddle MA, Scahill L, et al. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder in Tourette's syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry. 1995;34:1140-1146.
24. Hunt RD, Arnsten AFT, Asbel MD. An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995;34:50-54.
25. Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and ADHD. Am J Psychiatry. 2001;158:1067-1074.